Table 2.
Percentage of symptom-free days and days with no intake of rescue salbutamol during head-to-head clinical trial of BDP/F vs BUD/F in asthma (Derived from data of Papi et al 2007a)
| Symptom-free days (%) | Days with no intake of rescue salbutamol (%) | |
|---|---|---|
| BDP/F | ||
| Baseline | 2.61 | 1.62 |
| Last 2 weeks | 41.93a | 52.07a |
| BUD/F | ||
| Baseline | 3.52 | 2.97 |
| Last 2 weeks | 37.75a | 48.92a |
a
p < 0.001 vs baseline, no significant difference between treatments.Values are the mean values of the last week of the run-in period (baseline) and the last 2 weeks of treatment.
Abbreviations: BDP/F, beclomethasone dipropionate/formoterol; BUD/F, budesonide/formoterol.